{"id":22971,"date":"2026-09-30T09:20:20","date_gmt":"2026-09-30T07:20:20","guid":{"rendered":"https:\/\/mic-site.labiux.com\/riskdzivotaju-diena-aicina-latvijas-gimenes-izzinat-parmantota-veza-risku\/"},"modified":"2026-09-30T09:20:20","modified_gmt":"2026-09-30T07:20:20","slug":"riskdzivotaju-diena-aicina-latvijas-gimenes-izzinat-parmantota-veza-risku","status":"publish","type":"post","link":"https:\/\/farmacija-mic.lv\/en\/riskdzivotaju-diena-aicina-latvijas-gimenes-izzinat-parmantota-veza-risku\/","title":{"rendered":"Riskdz\u012bvot\u0101ju dien\u0101 aicina Latvijas \u0123imenes izzin\u0101t p\u0101rmantota v\u0113\u017ea risku"},"content":{"rendered":"<div class=\"wp-block-labiux-legacy-html legacy-content\">\n<p>30. septembr\u012b, starptautiski atz\u012bm\u0113taj\u0101 Riskdz\u012bvot\u0101ju dien\u0101, p\u0101rmantota v\u0113\u017ea pacientu atbalsta organiz\u0101cija DROSMES G\u0112NI piev\u0113r\u0161 sabiedr\u012bbas uzman\u012bbu cilv\u0113kiem, kuriem \u0123en\u0113tisku izmai\u0146u d\u0113\u013c ir b\u016btiski paaugstin\u0101ts risks dz\u012bves laik\u0101 saslimt ar v\u0113zi. Latvij\u0101 daudzi par savu risku pat nenojau\u0161, lai gan savlaic\u012bga t\u0101 apzin\u0101\u0161ana var pal\u012bdz\u0113t nov\u0113rst slim\u012bbu vai atkl\u0101t to agr\u012bn\u0101 stadij\u0101. Lai uzticama inform\u0101cija par p\u0101rmantotu v\u0113zi b\u016btu pieejama ikvienam, organiz\u0101cija izveidojusi jaunu inform\u0101cijas platformu drosmesgeni.lv.<\/p>\n<p>Tie\u0161i \u0161odien, 30. septembr\u012b, P\u0101rmantota v\u0113\u017ea ned\u0113\u013cas ietvaros citviet pasaul\u0113 tiek atz\u012bm\u0113ta Previvor Day jeb Riskdz\u012bvot\u0101ju diena. T\u0101s m\u0113r\u0137is ir veicin\u0101t izpratni par \u0123en\u0113tiski p\u0101rmantota v\u0113\u017ea risku un iesp\u0113j\u0101m, ko sniedz savlaic\u012bga t\u0101 apzin\u0101\u0161ana.<\/p>\n<p>Riskdz\u012bvot\u0101ji nav pacienti tradicion\u0101laj\u0101 izpratn\u0113. \u0160iem cilv\u0113kiem v\u0113l nav v\u0113\u017ea diagnozes \u2013 vi\u0146i ir piln\u012bgi veseli. Tom\u0113r mantojum\u0101 no iepriek\u0161\u0113j\u0101m paaudz\u0113m tie n\u0113s\u0101 k\u0101du no g\u0113nu patog\u0113najiem variantiem, kas var rad\u012bt b\u016btiski liel\u0101ku iesp\u0113ju dz\u012bves laik\u0101 saslimt ar noteiktiem v\u0113\u017ea veidiem.<\/p>\n<p>\u0160\u012b sabiedr\u012bbas da\u013ca bie\u017ei paliek neredzama, jo neiederas ierastaj\u0101 dal\u012bjum\u0101 starp veselu cilv\u0113ku un onkolo\u0123ijas pacientu. Ang\u013cu valod\u0101 min\u0113t\u0101s kopienas apz\u012bm\u0113\u0161anai izmanto v\u0101rdu previvor, ta\u010du latvie\u0161u valod\u0101 apz\u012bm\u0113juma l\u012bdz \u0161im nebija. Atsaucoties organiz\u0101cijas DROSMES G\u0112NI iniciat\u012bvai rast terminam atbilsmi dzimtaj\u0101 valod\u0101, Latvijas Zin\u0101t\u0146u akad\u0113mijas Terminolo\u0123ijas komisijas \u0161\u0101 gada mart\u0101 apstiprin\u0101ja jauna termina riskdz\u012bvot\u0101js ievie\u0161anu.<\/p>\n<p>\u201cTermins riskdz\u012bvot\u0101js mums bija nepiecie\u0161ams t\u0101p\u0113c, ka Latvij\u0101 l\u012bdz \u0161im nebija v\u0101rda cilv\u0113kam, kur\u0161 zina par savu paaugstin\u0101to v\u0113\u017ea risku un apzin\u0101ti r\u012bkojas, lai iesp\u0113ju robe\u017e\u0101s slim\u012bbu nepie\u013cautu vai atkl\u0101tu to p\u0113c iesp\u0113jas agr\u0101k. Nosaucot \u0161o augsta riska izdz\u012bvo\u0161anas pieredzi v\u0101rd\u0101, m\u0113s padar\u0101m redzamus ar\u012b pa\u0161us cilv\u0113kus,\u201d skaidro <strong>L\u012bga And\u017e\u0101ne<\/strong>, viena no p\u0101rmantota v\u0113\u017ea pacientu atbalsta organiz\u0101cijas DROSMES G\u0112NI l\u012bdzdibin\u0101t\u0101j\u0101m.<\/p>\n<p><strong>Zin\u0101t savu risku \u2013 ieg\u016bt iesp\u0113ju r\u012bkoties<\/strong><\/p>\n<p>Tiek l\u0113sts, ka aptuveni 5-10 % visu v\u0113\u017ea gad\u012bjumu ir saist\u012bti ar iedzimt\u0101m patog\u0113n\u0101m izmai\u0146\u0101m g\u0113nos. P\u0101rmantota v\u0113\u017ea risks nenoz\u012bm\u0113, ka cilv\u0113ks noteikti saslims ar v\u0113zi. Ta\u010du zin\u0101\u0161anas par savu \u0123en\u0113tisko mantojumu var main\u012bt to, k\u0101 r\u016bp\u0113jamies par savu vesel\u012bbu.<\/p>\n<p>K\u0101 st\u0101sta Paula Stradi\u0146a kl\u012bnisk\u0101s universit\u0101tes slimn\u012bcas kr\u016bts \u0137irurgs un RSU Onkolo\u0123ijas un molekul\u0101r\u0101s \u0123en\u0113tikas instit\u016bta vado\u0161ais p\u0113tnieks, asoci\u0113tais profesors Arv\u012bds Irmejs, Latvij\u0101 aptuveni 10 % kr\u016bts v\u0113\u017ea un 20 % oln\u012bcu v\u0113\u017ea gad\u012bjumu visbie\u017e\u0101k saist\u012bti ar patog\u0113niem BRCA g\u0113nu variantiem un ir p\u0101rmantoti. Sieviet\u0113m ar BRCA g\u0113nu mut\u0101cij\u0101m risks saslimt ar kr\u016bts v\u0113zi dz\u012bves laik\u0101 ir l\u012bdz pat 72 %, ar oln\u012bcu v\u0113zi \u2013 l\u012bdz 58 %.<\/p>\n<p>\u201cAtkar\u012bb\u0101 no konkr\u0113t\u0101s \u0123en\u0113tisk\u0101s izmai\u0146as un individu\u0101l\u0101 riska \u0101rsti var rekomend\u0113t agr\u0101k s\u0101ktus vai bie\u017e\u0101kus izmekl\u0113jumus, \u012bpa\u0161as nov\u0113ro\u0161anas programmas un atsevi\u0161\u0137os gad\u012bjumos ar\u012b risku samazino\u0161as oper\u0101cijas. Savlaic\u012bga sava \u0123en\u0113tisk\u0101 mantojuma izzin\u0101\u0161ana var b\u016bt noz\u012bm\u012bga ar\u012b \u0123imenei, jo iedzimtas \u0123en\u0113tiskas izmai\u0146as var tikt nodotas no paaudzes paaudz\u0113,\u201d skaidro A. Irmejs.<\/p>\n<p>Kr\u016bts v\u0113zis joproj\u0101m ir ne vien izplat\u012bt\u0101kais \u013caundab\u012bgais audz\u0113js Latvijas sievie\u0161u vid\u016b, bet ar\u012b viens no bie\u017e\u0101kajiem priek\u0161laic\u012bgas mirst\u012bbas c\u0113lo\u0146iem sieviet\u0113m p\u0113c 35 gadu vecuma. Savuk\u0101rt saska\u0146\u0101 ar OECD datiem mirst\u012bba no oln\u012bcu v\u0113\u017ea Latvij\u0101 ir viena no augst\u0101kaj\u0101m Eiropas Savien\u012bb\u0101. Oln\u012bcu v\u0113zi m\u0113dz d\u0113v\u0113t par kluso slepkavu, jo pa\u0161laik nav efekt\u012bvu skr\u012bninga meto\u017eu, kas \u013cautu to atkl\u0101t agr\u012bn\u0101 stadij\u0101.<\/p>\n<p>\u201cManu \u0123imeni v\u0113zis sk\u0101ris tr\u012bs paaudz\u0113s. Vecm\u0101mi\u0146a nomira no kr\u016bts v\u0113\u017ea, kad man bija tikai divi gadi. Mamma saslima vispirms ar oln\u012bcu, v\u0113l\u0101k \u2013 ar kr\u016bts v\u0113zi. Ar\u012b man tika diagnostic\u0113ts kr\u016bts v\u0113zis,\u201d pieredz\u0113 dal\u0101s \u017eurn\u0101liste un gr\u0101matu autore <strong>Inita Sila<\/strong>, DROSMES G\u0112NI valdes priek\u0161s\u0113d\u0113t\u0101ja un l\u012bdzdibin\u0101t\u0101ja. \u201cJau pirmaj\u0101 viz\u012bt\u0113 \u0101rsts ieteica veikt \u0123en\u0113tisko testu, kas apstiprin\u0101ja patog\u0113nas izmai\u0146as BRCA1 g\u0113n\u0101. Tikai v\u0113l\u0101k uzzin\u0101ju, ka \u0161\u012b mut\u0101cija iepriek\u0161 atkl\u0101ta ar\u012b mammai. Ja toreiz b\u016btu izpratusi, ko noz\u012bm\u0113 p\u0101rmantots v\u0113zis un ko varu dar\u012bt profilaktiski, iesp\u0113jams, mana dz\u012bve b\u016btu izv\u0113rtusies cit\u0101di. Varb\u016bt es b\u016btu izvair\u012bjusies no slim\u012bbas vai t\u0101 tiktu atkl\u0101ta agr\u012bn\u0101k. T\u0101p\u0113c aicin\u0101m ikvienu \u0123imeni, kur\u0101 biju\u0161i onkolo\u0123ijas gad\u012bjumi, izzin\u0101t iesp\u0113jas p\u0101rbaud\u012bt savu \u0123en\u0113tisko risku. K\u0101 pacientu intere\u0161u p\u0101rst\u0101v\u012bbas organiz\u0101cija v\u0113lamies, lai cilv\u0113kiem ar augstu p\u0101rmantota v\u0113\u017ea risku b\u016btu pieejama nepiecie\u0161am\u0101 profilakse un vesel\u012bbas apr\u016bpe.\u201d<\/p>\n<p><strong>Pirmo reizi par p\u0101rmantotu v\u0113zi vienuviet<\/strong><\/p>\n<p>Lai cilv\u0113kiem ar iesp\u0113jamu p\u0101rmantota v\u0113\u017ea risku vai \u0123en\u0113tiskaj\u0101 test\u0101 jau apstiprin\u0101t\u0101m izmai\u0146\u0101m g\u0113nos b\u016btu pieejama uzticama un p\u0101rbaud\u012bta inform\u0101cija, organiz\u0101cija DROSMES G\u0112NI sadarb\u012bb\u0101 ar Latvijas liel\u0101ko universit\u0101tes kl\u012bniku speci\u0101listiem izveidojusi pirmo pacientiem un vi\u0146u \u0123imen\u0113m paredz\u0113to platformu, kur\u0101 viss svar\u012bg\u0101kais par p\u0101rmanotajiem v\u0113\u017eiem apkopots vienuviet \u2013 drosmesgeni.lv.<\/p>\n<p>Platform\u0101 skaidrots, kam b\u016btu v\u0113rts izv\u0113rt\u0113t savu \u0123imenes onkolo\u0123isko slim\u012bbu v\u0113sturi, kad v\u0113rts apsv\u0113rt \u0123en\u0113tisko test\u0113\u0161anu, ko noz\u012bm\u0113 da\u017e\u0101du g\u0113nu izmai\u0146as un k\u0101das ir profilakses iesp\u0113jas p\u0113c paaugstin\u0101ta riska konstat\u0113\u0161anas.<\/p>\n<p>Jaunais resurss, kas tapis ar Sabiedr\u012bbas Integr\u0101cijas fonda finansi\u0101lu atbalstu par Latvijas valsts bud\u017eeta l\u012bdzek\u013ciem, apvieno riskdz\u012bvot\u0101ju person\u012bgo pieredzi ar uzticamu, pier\u0101d\u012bjumos balst\u012btu inform\u0101ciju, lai sare\u017e\u0123\u012btus jaut\u0101jumus par \u0123en\u0113tiku un v\u0113\u017ea risku padar\u012btu saprotamus un pal\u012bdz\u0113tu riskdz\u012bvot\u0101jiem pie\u0146emt inform\u0113tus l\u0113mumus par savu vesel\u012bbu.<\/p>\n<p><strong>Par organiz\u0101ciju<\/strong><\/p>\n<p>DROSMES G\u0112NI ir 2025. gad\u0101 dibin\u0101ta nevalstiska organiz\u0101cija, kuras m\u0113r\u0137is ir veicin\u0101t sabiedr\u012bbas izpratni un inform\u0113t\u012bbu par p\u0101rmantota v\u0113\u017ea risku, k\u0101 ar\u012b uzlabot \u0123en\u0113tisk\u0101s test\u0113\u0161anas, profilakses un atbalsta pieejam\u012bbu cilv\u0113kiem un \u0123imen\u0113m ar p\u0101rmanota v\u0113\u017ea risku. Organiz\u0101cijas ilgtermi\u0146a m\u0113r\u0137is ir p\u0101rraut p\u0101rmantota v\u0113\u017ea ciklu Latvijas \u0123imen\u0113s.<\/p>\n<p>Avots: LETA<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>30. septembr\u012b, starptautiski atz\u012bm\u0113taj\u0101 Riskdz\u012bvot\u0101ju dien\u0101, p\u0101rmantota v\u0113\u017ea pacientu atbalsta organiz\u0101cija DROSMES G\u0112NI piev\u0113r\u0161 sabiedr\u012bbas uzman\u012bbu cilv\u0113kiem, kuriem \u0123en\u0113tisku izmai\u0146u d\u0113\u013c ir b\u016btiski paaugstin\u0101ts risks dz\u012bves laik\u0101 saslimt ar v\u0113zi. [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":13861,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"mic_cinema_image":0,"mic_focus":"","mic_cinema_focus":"","footnotes":"","_labiux_rail":0},"categories":[71,76],"tags":[2978,2979,2977,301],"mic_flag":[],"class_list":["post-22971","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-interesanti-fakti","category-jaunakie-raksti","tag-drosmes-geni","tag-parmantota-veza-nedela","tag-riskdzivotaju-diena","tag-vezis"],"aioseo_notices":[],"aioseo_head":"\n\t\t<!-- All in One SEO 5.0.4 - aioseo.com -->\n\t<meta name=\"description\" content=\"30. septembr\u012b, starptautiski atz\u012bm\u0113taj\u0101 Riskdz\u012bvot\u0101ju dien\u0101, p\u0101rmantota v\u0113\u017ea pacientu atbalsta organiz\u0101cija DROSMES G\u0112NI piev\u0113r\u0161 sabiedr\u012bbas uzman\u012bbu cilv\u0113kiem, kuriem \u0123en\u0113tisku izmai\u0146u d\u0113\u013c ir b\u016btiski paaugstin\u0101ts risks dz\u012bves laik\u0101 saslimt ar v\u0113zi. Latvij\u0101 daudzi par savu risku pat nenojau\u0161, lai gan savlaic\u012bga t\u0101 apzin\u0101\u0161ana var pal\u012bdz\u0113t nov\u0113rst slim\u012bbu vai atkl\u0101t to agr\u012bn\u0101 stadij\u0101. Lai uzticama inform\u0101cija par\" \/>\n\t<meta name=\"robots\" content=\"max-image-preview:large\" \/>\n\t<meta name=\"author\" content=\"admin\"\/>\n\t<link rel=\"canonical\" href=\"https:\/\/farmacija-mic.lv\/en\/riskdzivotaju-diena-aicina-latvijas-gimenes-izzinat-parmantota-veza-risku\/\" \/>\n\t\t<meta name=\"generator\" content=\"All in One SEO (AIOSEO) 5.0.4\" \/>\n\t\t<meta property=\"og:locale\" content=\"en_US\" \/>\n\t\t<meta property=\"og:site_name\" content=\"Medikamentu Inform\u0101cijas Centrs\" \/>\n\t\t<meta property=\"og:type\" content=\"article\" \/>\n\t\t<meta property=\"og:title\" content=\"Riskdz\u012bvot\u0101ju dien\u0101 aicina Latvijas \u0123imenes izzin\u0101t p\u0101rmantota v\u0113\u017ea risku - Medikamentu Inform\u0101cijas Centrs\" \/>\n\t\t<meta property=\"og:description\" content=\"30. septembr\u012b, starptautiski atz\u012bm\u0113taj\u0101 Riskdz\u012bvot\u0101ju dien\u0101, p\u0101rmantota v\u0113\u017ea pacientu atbalsta organiz\u0101cija DROSMES G\u0112NI piev\u0113r\u0161 sabiedr\u012bbas uzman\u012bbu cilv\u0113kiem, kuriem \u0123en\u0113tisku izmai\u0146u d\u0113\u013c ir b\u016btiski paaugstin\u0101ts risks dz\u012bves laik\u0101 saslimt ar v\u0113zi. Latvij\u0101 daudzi par savu risku pat nenojau\u0161, lai gan savlaic\u012bga t\u0101 apzin\u0101\u0161ana var pal\u012bdz\u0113t nov\u0113rst slim\u012bbu vai atkl\u0101t to agr\u012bn\u0101 stadij\u0101. Lai uzticama inform\u0101cija par\" \/>\n\t\t<meta property=\"og:url\" content=\"https:\/\/farmacija-mic.lv\/en\/riskdzivotaju-diena-aicina-latvijas-gimenes-izzinat-parmantota-veza-risku\/\" \/>\n\t\t<meta property=\"og:image\" content=\"https:\/\/farmacija-mic.lv\/wp-content\/uploads\/2024\/05\/onkologija-oncology-pacients-patient-arsts-doctor-care.jpg\" \/>\n\t\t<meta property=\"og:image:secure_url\" content=\"https:\/\/farmacija-mic.lv\/wp-content\/uploads\/2024\/05\/onkologija-oncology-pacients-patient-arsts-doctor-care.jpg\" \/>\n\t\t<meta property=\"og:image:width\" content=\"1330\" \/>\n\t\t<meta property=\"og:image:height\" content=\"500\" \/>\n\t\t<meta property=\"article:published_time\" content=\"2026-09-30T07:20:20+00:00\" \/>\n\t\t<meta property=\"article:modified_time\" content=\"2026-09-30T07:20:20+00:00\" \/>\n\t\t<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n\t\t<meta name=\"twitter:title\" content=\"Riskdz\u012bvot\u0101ju dien\u0101 aicina Latvijas \u0123imenes izzin\u0101t p\u0101rmantota v\u0113\u017ea risku - Medikamentu Inform\u0101cijas Centrs\" \/>\n\t\t<meta name=\"twitter:description\" content=\"30. septembr\u012b, starptautiski atz\u012bm\u0113taj\u0101 Riskdz\u012bvot\u0101ju dien\u0101, p\u0101rmantota v\u0113\u017ea pacientu atbalsta organiz\u0101cija DROSMES G\u0112NI piev\u0113r\u0161 sabiedr\u012bbas uzman\u012bbu cilv\u0113kiem, kuriem \u0123en\u0113tisku izmai\u0146u d\u0113\u013c ir b\u016btiski paaugstin\u0101ts risks dz\u012bves laik\u0101 saslimt ar v\u0113zi. Latvij\u0101 daudzi par savu risku pat nenojau\u0161, lai gan savlaic\u012bga t\u0101 apzin\u0101\u0161ana var pal\u012bdz\u0113t nov\u0113rst slim\u012bbu vai atkl\u0101t to agr\u012bn\u0101 stadij\u0101. Lai uzticama inform\u0101cija par\" \/>\n\t\t<meta name=\"twitter:image\" content=\"https:\/\/farmacija-mic.lv\/wp-content\/uploads\/2024\/05\/onkologija-oncology-pacients-patient-arsts-doctor-care.jpg\" \/>\n\t\t<script type=\"application\/ld+json\" class=\"aioseo-schema\">\n\t\t\t{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/riskdzivotaju-diena-aicina-latvijas-gimenes-izzinat-parmantota-veza-risku\\\/#breadcrumblist\",\"itemListElement\":[{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/#listItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/category\\\/interesanti-fakti\\\/#listItem\",\"name\":\"Interesanti\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/category\\\/interesanti-fakti\\\/#listItem\",\"position\":2,\"name\":\"Interesanti\",\"item\":\"https:\\\/\\\/farmacija-mic.lv\\\/category\\\/interesanti-fakti\\\/\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/riskdzivotaju-diena-aicina-latvijas-gimenes-izzinat-parmantota-veza-risku\\\/#listItem\",\"name\":\"Riskdz\\u012bvot\\u0101ju dien\\u0101 aicina Latvijas \\u0123imenes izzin\\u0101t p\\u0101rmantota v\\u0113\\u017ea risku\"},\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/#listItem\",\"name\":\"Home\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/riskdzivotaju-diena-aicina-latvijas-gimenes-izzinat-parmantota-veza-risku\\\/#listItem\",\"position\":3,\"name\":\"Riskdz\\u012bvot\\u0101ju dien\\u0101 aicina Latvijas \\u0123imenes izzin\\u0101t p\\u0101rmantota v\\u0113\\u017ea risku\",\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/category\\\/interesanti-fakti\\\/#listItem\",\"name\":\"Interesanti\"}}]},{\"@type\":\"NewsArticle\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/riskdzivotaju-diena-aicina-latvijas-gimenes-izzinat-parmantota-veza-risku\\\/#newsarticle\",\"name\":\"Riskdz\\u012bvot\\u0101ju dien\\u0101 aicina Latvijas \\u0123imenes izzin\\u0101t p\\u0101rmantota v\\u0113\\u017ea risku - Medikamentu Inform\\u0101cijas Centrs\",\"headline\":\"Riskdz\\u012bvot\\u0101ju dien\\u0101 aicina Latvijas \\u0123imenes izzin\\u0101t p\\u0101rmantota v\\u0113\\u017ea risku\",\"author\":{\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/author\\\/admin\\\/#author\"},\"publisher\":{\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/#organization\"},\"image\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\/\\\/farmacija-mic.lv\\\/wp-content\\\/uploads\\\/2024\\\/05\\\/onkologija-oncology-pacients-patient-arsts-doctor-care.jpg\",\"width\":1330,\"height\":500},\"datePublished\":\"2026-09-30T09:20:20+03:00\",\"dateModified\":\"2026-09-30T09:20:20+03:00\",\"inLanguage\":\"en-US\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/riskdzivotaju-diena-aicina-latvijas-gimenes-izzinat-parmantota-veza-risku\\\/#webpage\"},\"isPartOf\":{\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/riskdzivotaju-diena-aicina-latvijas-gimenes-izzinat-parmantota-veza-risku\\\/#webpage\"},\"articleSection\":\"Interesanti, Jaun\\u0101kie raksti, Drosmes g\\u0113ni, P\\u0101rmantota v\\u0113\\u017ea ned\\u0113\\u013ca, Riskdz\\u012bvot\\u0101ju diena, v\\u0113zis\",\"dateline\":\"Published on September 30, 2026.\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/#organization\",\"name\":\"Medikamentu Inform\\u0101cijas Centrs\",\"description\":\"Farm\\u0101cijas nozares port\\u0101ls farmaceitiem un \\u0101rstiem. Zi\\u0146as, normat\\u012bvie akti, pas\\u0101kumi un t\\u0101l\\u0101kizgl\\u012bt\\u012bba vienuviet kop\\u0161 2001. gada.\",\"url\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/author\\\/admin\\\/#author\",\"url\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/author\\\/admin\\\/\",\"name\":\"admin\",\"image\":{\"@type\":\"ImageObject\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/riskdzivotaju-diena-aicina-latvijas-gimenes-izzinat-parmantota-veza-risku\\\/#authorImage\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/be3221a6fac131657111728b4d912a877ec158b123d5db3afef3bd8a59784ece?s=96&d=mm&r=g\",\"width\":96,\"height\":96,\"caption\":\"admin\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/riskdzivotaju-diena-aicina-latvijas-gimenes-izzinat-parmantota-veza-risku\\\/#webpage\",\"url\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/riskdzivotaju-diena-aicina-latvijas-gimenes-izzinat-parmantota-veza-risku\\\/\",\"name\":\"Riskdz\\u012bvot\\u0101ju dien\\u0101 aicina Latvijas \\u0123imenes izzin\\u0101t p\\u0101rmantota v\\u0113\\u017ea risku - Medikamentu Inform\\u0101cijas Centrs\",\"description\":\"30. septembr\\u012b, starptautiski atz\\u012bm\\u0113taj\\u0101 Riskdz\\u012bvot\\u0101ju dien\\u0101, p\\u0101rmantota v\\u0113\\u017ea pacientu atbalsta organiz\\u0101cija DROSMES G\\u0112NI piev\\u0113r\\u0161 sabiedr\\u012bbas uzman\\u012bbu cilv\\u0113kiem, kuriem \\u0123en\\u0113tisku izmai\\u0146u d\\u0113\\u013c ir b\\u016btiski paaugstin\\u0101ts risks dz\\u012bves laik\\u0101 saslimt ar v\\u0113zi. Latvij\\u0101 daudzi par savu risku pat nenojau\\u0161, lai gan savlaic\\u012bga t\\u0101 apzin\\u0101\\u0161ana var pal\\u012bdz\\u0113t nov\\u0113rst slim\\u012bbu vai atkl\\u0101t to agr\\u012bn\\u0101 stadij\\u0101. Lai uzticama inform\\u0101cija par\",\"inLanguage\":\"en-US\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/#website\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/riskdzivotaju-diena-aicina-latvijas-gimenes-izzinat-parmantota-veza-risku\\\/#breadcrumblist\"},\"author\":{\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/author\\\/admin\\\/#author\"},\"creator\":{\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/author\\\/admin\\\/#author\"},\"image\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\/\\\/farmacija-mic.lv\\\/wp-content\\\/uploads\\\/2024\\\/05\\\/onkologija-oncology-pacients-patient-arsts-doctor-care.jpg\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/riskdzivotaju-diena-aicina-latvijas-gimenes-izzinat-parmantota-veza-risku\\\/#mainImage\",\"width\":1330,\"height\":500},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/riskdzivotaju-diena-aicina-latvijas-gimenes-izzinat-parmantota-veza-risku\\\/#mainImage\"},\"datePublished\":\"2026-09-30T09:20:20+03:00\",\"dateModified\":\"2026-09-30T09:20:20+03:00\"},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/\",\"name\":\"Medikamentu Inform\\u0101cijas Centrs\",\"description\":\"Farm\\u0101cijas nozares port\\u0101ls farmaceitiem un \\u0101rstiem. Zi\\u0146as, normat\\u012bvie akti, pas\\u0101kumi un t\\u0101l\\u0101kizgl\\u012bt\\u012bba vienuviet kop\\u0161 2001. gada.\",\"inLanguage\":\"en-US\",\"publisher\":{\"@id\":\"https:\\\/\\\/farmacija-mic.lv\\\/en\\\/#organization\"}}]}\n\t\t<\/script>\n\t\t<!-- All in One SEO -->\n\n","aioseo_head_json":{"title":"Riskdz\u012bvot\u0101ju dien\u0101 aicina Latvijas \u0123imenes izzin\u0101t p\u0101rmantota v\u0113\u017ea risku - Medikamentu Inform\u0101cijas Centrs","description":"30. septembr\u012b, starptautiski atz\u012bm\u0113taj\u0101 Riskdz\u012bvot\u0101ju dien\u0101, p\u0101rmantota v\u0113\u017ea pacientu atbalsta organiz\u0101cija DROSMES G\u0112NI piev\u0113r\u0161 sabiedr\u012bbas uzman\u012bbu cilv\u0113kiem, kuriem \u0123en\u0113tisku izmai\u0146u d\u0113\u013c ir b\u016btiski paaugstin\u0101ts risks dz\u012bves laik\u0101 saslimt ar v\u0113zi. Latvij\u0101 daudzi par savu risku pat nenojau\u0161, lai gan savlaic\u012bga t\u0101 apzin\u0101\u0161ana var pal\u012bdz\u0113t nov\u0113rst slim\u012bbu vai atkl\u0101t to agr\u012bn\u0101 stadij\u0101. Lai uzticama inform\u0101cija par","canonical_url":"https:\/\/farmacija-mic.lv\/en\/riskdzivotaju-diena-aicina-latvijas-gimenes-izzinat-parmantota-veza-risku\/","robots":"max-image-preview:large","keywords":"","webmasterTools":{"miscellaneous":""},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"BreadcrumbList","@id":"https:\/\/farmacija-mic.lv\/en\/riskdzivotaju-diena-aicina-latvijas-gimenes-izzinat-parmantota-veza-risku\/#breadcrumblist","itemListElement":[{"@type":"ListItem","@id":"https:\/\/farmacija-mic.lv\/en\/#listItem","position":1,"name":"Home","item":"https:\/\/farmacija-mic.lv\/en\/","nextItem":{"@type":"ListItem","@id":"https:\/\/farmacija-mic.lv\/category\/interesanti-fakti\/#listItem","name":"Interesanti"}},{"@type":"ListItem","@id":"https:\/\/farmacija-mic.lv\/category\/interesanti-fakti\/#listItem","position":2,"name":"Interesanti","item":"https:\/\/farmacija-mic.lv\/category\/interesanti-fakti\/","nextItem":{"@type":"ListItem","@id":"https:\/\/farmacija-mic.lv\/en\/riskdzivotaju-diena-aicina-latvijas-gimenes-izzinat-parmantota-veza-risku\/#listItem","name":"Riskdz\u012bvot\u0101ju dien\u0101 aicina Latvijas \u0123imenes izzin\u0101t p\u0101rmantota v\u0113\u017ea risku"},"previousItem":{"@type":"ListItem","@id":"https:\/\/farmacija-mic.lv\/en\/#listItem","name":"Home"}},{"@type":"ListItem","@id":"https:\/\/farmacija-mic.lv\/en\/riskdzivotaju-diena-aicina-latvijas-gimenes-izzinat-parmantota-veza-risku\/#listItem","position":3,"name":"Riskdz\u012bvot\u0101ju dien\u0101 aicina Latvijas \u0123imenes izzin\u0101t p\u0101rmantota v\u0113\u017ea risku","previousItem":{"@type":"ListItem","@id":"https:\/\/farmacija-mic.lv\/category\/interesanti-fakti\/#listItem","name":"Interesanti"}}]},{"@type":"NewsArticle","@id":"https:\/\/farmacija-mic.lv\/en\/riskdzivotaju-diena-aicina-latvijas-gimenes-izzinat-parmantota-veza-risku\/#newsarticle","name":"Riskdz\u012bvot\u0101ju dien\u0101 aicina Latvijas \u0123imenes izzin\u0101t p\u0101rmantota v\u0113\u017ea risku - Medikamentu Inform\u0101cijas Centrs","headline":"Riskdz\u012bvot\u0101ju dien\u0101 aicina Latvijas \u0123imenes izzin\u0101t p\u0101rmantota v\u0113\u017ea risku","author":{"@id":"https:\/\/farmacija-mic.lv\/en\/author\/admin\/#author"},"publisher":{"@id":"https:\/\/farmacija-mic.lv\/en\/#organization"},"image":{"@type":"ImageObject","url":"https:\/\/farmacija-mic.lv\/wp-content\/uploads\/2024\/05\/onkologija-oncology-pacients-patient-arsts-doctor-care.jpg","width":1330,"height":500},"datePublished":"2026-09-30T09:20:20+03:00","dateModified":"2026-09-30T09:20:20+03:00","inLanguage":"en-US","mainEntityOfPage":{"@id":"https:\/\/farmacija-mic.lv\/en\/riskdzivotaju-diena-aicina-latvijas-gimenes-izzinat-parmantota-veza-risku\/#webpage"},"isPartOf":{"@id":"https:\/\/farmacija-mic.lv\/en\/riskdzivotaju-diena-aicina-latvijas-gimenes-izzinat-parmantota-veza-risku\/#webpage"},"articleSection":"Interesanti, Jaun\u0101kie raksti, Drosmes g\u0113ni, P\u0101rmantota v\u0113\u017ea ned\u0113\u013ca, Riskdz\u012bvot\u0101ju diena, v\u0113zis","dateline":"Published on September 30, 2026."},{"@type":"Organization","@id":"https:\/\/farmacija-mic.lv\/en\/#organization","name":"Medikamentu Inform\u0101cijas Centrs","description":"Farm\u0101cijas nozares port\u0101ls farmaceitiem un \u0101rstiem. Zi\u0146as, normat\u012bvie akti, pas\u0101kumi un t\u0101l\u0101kizgl\u012bt\u012bba vienuviet kop\u0161 2001. gada.","url":"https:\/\/farmacija-mic.lv\/en\/"},{"@type":"Person","@id":"https:\/\/farmacija-mic.lv\/en\/author\/admin\/#author","url":"https:\/\/farmacija-mic.lv\/en\/author\/admin\/","name":"admin","image":{"@type":"ImageObject","@id":"https:\/\/farmacija-mic.lv\/en\/riskdzivotaju-diena-aicina-latvijas-gimenes-izzinat-parmantota-veza-risku\/#authorImage","url":"https:\/\/secure.gravatar.com\/avatar\/be3221a6fac131657111728b4d912a877ec158b123d5db3afef3bd8a59784ece?s=96&d=mm&r=g","width":96,"height":96,"caption":"admin"}},{"@type":"WebPage","@id":"https:\/\/farmacija-mic.lv\/en\/riskdzivotaju-diena-aicina-latvijas-gimenes-izzinat-parmantota-veza-risku\/#webpage","url":"https:\/\/farmacija-mic.lv\/en\/riskdzivotaju-diena-aicina-latvijas-gimenes-izzinat-parmantota-veza-risku\/","name":"Riskdz\u012bvot\u0101ju dien\u0101 aicina Latvijas \u0123imenes izzin\u0101t p\u0101rmantota v\u0113\u017ea risku - Medikamentu Inform\u0101cijas Centrs","description":"30. septembr\u012b, starptautiski atz\u012bm\u0113taj\u0101 Riskdz\u012bvot\u0101ju dien\u0101, p\u0101rmantota v\u0113\u017ea pacientu atbalsta organiz\u0101cija DROSMES G\u0112NI piev\u0113r\u0161 sabiedr\u012bbas uzman\u012bbu cilv\u0113kiem, kuriem \u0123en\u0113tisku izmai\u0146u d\u0113\u013c ir b\u016btiski paaugstin\u0101ts risks dz\u012bves laik\u0101 saslimt ar v\u0113zi. Latvij\u0101 daudzi par savu risku pat nenojau\u0161, lai gan savlaic\u012bga t\u0101 apzin\u0101\u0161ana var pal\u012bdz\u0113t nov\u0113rst slim\u012bbu vai atkl\u0101t to agr\u012bn\u0101 stadij\u0101. Lai uzticama inform\u0101cija par","inLanguage":"en-US","isPartOf":{"@id":"https:\/\/farmacija-mic.lv\/en\/#website"},"breadcrumb":{"@id":"https:\/\/farmacija-mic.lv\/en\/riskdzivotaju-diena-aicina-latvijas-gimenes-izzinat-parmantota-veza-risku\/#breadcrumblist"},"author":{"@id":"https:\/\/farmacija-mic.lv\/en\/author\/admin\/#author"},"creator":{"@id":"https:\/\/farmacija-mic.lv\/en\/author\/admin\/#author"},"image":{"@type":"ImageObject","url":"https:\/\/farmacija-mic.lv\/wp-content\/uploads\/2024\/05\/onkologija-oncology-pacients-patient-arsts-doctor-care.jpg","@id":"https:\/\/farmacija-mic.lv\/en\/riskdzivotaju-diena-aicina-latvijas-gimenes-izzinat-parmantota-veza-risku\/#mainImage","width":1330,"height":500},"primaryImageOfPage":{"@id":"https:\/\/farmacija-mic.lv\/en\/riskdzivotaju-diena-aicina-latvijas-gimenes-izzinat-parmantota-veza-risku\/#mainImage"},"datePublished":"2026-09-30T09:20:20+03:00","dateModified":"2026-09-30T09:20:20+03:00"},{"@type":"WebSite","@id":"https:\/\/farmacija-mic.lv\/en\/#website","url":"https:\/\/farmacija-mic.lv\/en\/","name":"Medikamentu Inform\u0101cijas Centrs","description":"Farm\u0101cijas nozares port\u0101ls farmaceitiem un \u0101rstiem. Zi\u0146as, normat\u012bvie akti, pas\u0101kumi un t\u0101l\u0101kizgl\u012bt\u012bba vienuviet kop\u0161 2001. gada.","inLanguage":"en-US","publisher":{"@id":"https:\/\/farmacija-mic.lv\/en\/#organization"}}]},"og:locale":"en_US","og:site_name":"Medikamentu Inform\u0101cijas Centrs","og:type":"article","og:title":"Riskdz\u012bvot\u0101ju dien\u0101 aicina Latvijas \u0123imenes izzin\u0101t p\u0101rmantota v\u0113\u017ea risku - Medikamentu Inform\u0101cijas Centrs","og:description":"30. septembr\u012b, starptautiski atz\u012bm\u0113taj\u0101 Riskdz\u012bvot\u0101ju dien\u0101, p\u0101rmantota v\u0113\u017ea pacientu atbalsta organiz\u0101cija DROSMES G\u0112NI piev\u0113r\u0161 sabiedr\u012bbas uzman\u012bbu cilv\u0113kiem, kuriem \u0123en\u0113tisku izmai\u0146u d\u0113\u013c ir b\u016btiski paaugstin\u0101ts risks dz\u012bves laik\u0101 saslimt ar v\u0113zi. Latvij\u0101 daudzi par savu risku pat nenojau\u0161, lai gan savlaic\u012bga t\u0101 apzin\u0101\u0161ana var pal\u012bdz\u0113t nov\u0113rst slim\u012bbu vai atkl\u0101t to agr\u012bn\u0101 stadij\u0101. Lai uzticama inform\u0101cija par","og:url":"https:\/\/farmacija-mic.lv\/en\/riskdzivotaju-diena-aicina-latvijas-gimenes-izzinat-parmantota-veza-risku\/","og:image":"https:\/\/farmacija-mic.lv\/wp-content\/uploads\/2024\/05\/onkologija-oncology-pacients-patient-arsts-doctor-care.jpg","og:image:secure_url":"https:\/\/farmacija-mic.lv\/wp-content\/uploads\/2024\/05\/onkologija-oncology-pacients-patient-arsts-doctor-care.jpg","og:image:width":1330,"og:image:height":500,"article:published_time":"2026-09-30T07:20:20+00:00","article:modified_time":"2026-09-30T07:20:20+00:00","twitter:card":"summary_large_image","twitter:title":"Riskdz\u012bvot\u0101ju dien\u0101 aicina Latvijas \u0123imenes izzin\u0101t p\u0101rmantota v\u0113\u017ea risku - Medikamentu Inform\u0101cijas Centrs","twitter:description":"30. septembr\u012b, starptautiski atz\u012bm\u0113taj\u0101 Riskdz\u012bvot\u0101ju dien\u0101, p\u0101rmantota v\u0113\u017ea pacientu atbalsta organiz\u0101cija DROSMES G\u0112NI piev\u0113r\u0161 sabiedr\u012bbas uzman\u012bbu cilv\u0113kiem, kuriem \u0123en\u0113tisku izmai\u0146u d\u0113\u013c ir b\u016btiski paaugstin\u0101ts risks dz\u012bves laik\u0101 saslimt ar v\u0113zi. Latvij\u0101 daudzi par savu risku pat nenojau\u0161, lai gan savlaic\u012bga t\u0101 apzin\u0101\u0161ana var pal\u012bdz\u0113t nov\u0113rst slim\u012bbu vai atkl\u0101t to agr\u012bn\u0101 stadij\u0101. Lai uzticama inform\u0101cija par","twitter:image":"https:\/\/farmacija-mic.lv\/wp-content\/uploads\/2024\/05\/onkologija-oncology-pacients-patient-arsts-doctor-care.jpg"},"aioseo_meta_data":{"post_id":"22971","title":null,"description":null,"keywords":null,"keyphrases":{"focus":[],"additional":[]},"focus_keyword":null,"additional_keywords":null,"truseo_locale":null,"primary_term":null,"canonical_url":null,"og_title":null,"og_description":null,"og_object_type":"default","og_image_type":"default","og_image_custom_url":null,"og_image_custom_fields":null,"og_image_url":null,"og_image_width":null,"og_image_height":null,"og_video":null,"og_custom_url":null,"og_article_section":null,"og_article_tags":null,"twitter_use_og":false,"twitter_card":"default","twitter_image_type":"default","twitter_image_custom_url":null,"twitter_image_custom_fields":null,"twitter_image_url":null,"twitter_title":null,"twitter_description":null,"schema_type":"default","schema_type_options":null,"schema":{"blockGraphs":[],"customGraphs":[],"default":{"data":{"Article":[],"Course":[],"Dataset":[],"FAQPage":[],"Movie":[],"Person":[],"Product":[],"ProductReview":[],"Car":[],"Recipe":[],"Service":[],"SoftwareApplication":[],"WebPage":[]},"graphName":"","isEnabled":true},"graphs":[]},"pillar_content":false,"robots_default":true,"robots_noindex":false,"robots_noarchive":false,"robots_nosnippet":false,"robots_nofollow":false,"robots_noimageindex":false,"robots_noodp":false,"robots_notranslate":false,"robots_max_snippet":null,"robots_max_videopreview":null,"robots_max_imagepreview":"large","priority":null,"frequency":null,"local_seo":null,"limit_modified_date":false,"ai":null,"breadcrumb_settings":null,"seo_analyzer_scan_date":null,"created":"2026-10-16 21:05:03","updated":"2026-10-22 09:10:34"},"aioseo_breadcrumb":"<div class=\"aioseo-breadcrumbs\"><span class=\"aioseo-breadcrumb\">\n\t\t\t<a href=\"https:\/\/farmacija-mic.lv\/en\/\" title=\"Home\">Home<\/a>\n\t\t<\/span><span class=\"aioseo-breadcrumb-separator\">\u00bb<\/span><span class=\"aioseo-breadcrumb\">\n\t\t\t<a href=\"https:\/\/farmacija-mic.lv\/category\/interesanti-fakti\/\" title=\"Interesanti\">Interesanti<\/a>\n\t\t<\/span><span class=\"aioseo-breadcrumb-separator\">\u00bb<\/span><span class=\"aioseo-breadcrumb\">\n\t\t\tRiskdz\u012bvot\u0101ju dien\u0101 aicina Latvijas \u0123imenes izzin\u0101t p\u0101rmantota v\u0113\u017ea risku\n\t\t<\/span><\/div>","aioseo_breadcrumb_json":[{"label":"Home","link":"https:\/\/farmacija-mic.lv\/en\/"},{"label":"Interesanti","link":"https:\/\/farmacija-mic.lv\/category\/interesanti-fakti\/"},{"label":"Riskdz\u012bvot\u0101ju dien\u0101 aicina Latvijas \u0123imenes izzin\u0101t p\u0101rmantota v\u0113\u017ea risku","link":"https:\/\/farmacija-mic.lv\/en\/riskdzivotaju-diena-aicina-latvijas-gimenes-izzinat-parmantota-veza-risku\/"}],"_links":{"self":[{"href":"https:\/\/farmacija-mic.lv\/en\/wp-json\/wp\/v2\/posts\/22971","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/farmacija-mic.lv\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/farmacija-mic.lv\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/farmacija-mic.lv\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/farmacija-mic.lv\/en\/wp-json\/wp\/v2\/comments?post=22971"}],"version-history":[{"count":0,"href":"https:\/\/farmacija-mic.lv\/en\/wp-json\/wp\/v2\/posts\/22971\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/farmacija-mic.lv\/en\/wp-json\/wp\/v2\/media\/13861"}],"wp:attachment":[{"href":"https:\/\/farmacija-mic.lv\/en\/wp-json\/wp\/v2\/media?parent=22971"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/farmacija-mic.lv\/en\/wp-json\/wp\/v2\/categories?post=22971"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/farmacija-mic.lv\/en\/wp-json\/wp\/v2\/tags?post=22971"},{"taxonomy":"mic_flag","embeddable":true,"href":"https:\/\/farmacija-mic.lv\/en\/wp-json\/wp\/v2\/mic_flag?post=22971"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}